{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:38Z","timestamp":1786119098356,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Objectives:<\/jats:title>\n                    <jats:p>Cancer in infancy represents a unique and challenging entity. They differ clinically and biologically from childhood cancer, resulting in different management and outcomes. Cancer epidemiological studies and population-based registries among this age group are limited, herby we aimed to reflect our hospital-based data on the incidence and survival of cancer among infants over a 15-year period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>We retrospectively analyzed the clinical data of infants aged 0 to 12 months diagnosed with hematological malignancies and malignant solid tumors registered in the Pediatric Oncology Department of our university hospital from January 2006 to December 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Infant malignancies represented 4.6% of all pediatric malignancies diagnosed at our institute over the same study period. Hematological malignancies accounted for 18.3%, while solid malignant tumors accounted for 81.7%. Retinoblastoma was the most common malignant solid tumor in this study (39.7%), followed by neuroblastoma and germ cell tumor. The 5- and 10-year overall survival rates for hematological and solid tumors were 30.8% and 75.9%, respectively. The overall survival rates were highly significant among solid tumors compared with hematological malignancies (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u22640.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The prevalence of infant malignant tumors varies geographically. This study provides estimates on the incidence and survival rates of cancer among the infant age group in our country. Our overall survival rate was comparable to that reported in the literature. Collaborative research is required to achieve a more comprehensive understanding of infant cancer epidemiology and characteristics, with the aim of improving their prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003190","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:00:10Z","timestamp":1774645210000},"page":"153-159","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics and Outcome of Leukemia and Malignant Solid Tumors Among Infant Age Group: A 15-Year Study in a Tertiary Care Hospital in Egypt"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2835-5068","authenticated-orcid":false,"given":"Esraa M.A.","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayera H.K.","family":"Elsherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"R1-20260423","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/08880010591002233","article-title":"Cancer in infants: a review of 82 cases","volume":"22","author":"Yang","year":"2005","journal-title":"Pediatr Hematol Oncol"},{"key":"R2-20260423","doi-asserted-by":"crossref","first-page":"418","DOI":"10.7196\/SAMJ.2022.v112i6.15823","article-title":"Solid malignancies during the first year of life: A 20-year review at Red Cross War Memorial Children\u2019s Hospital, Cape Town, South Africa","volume":"112","author":"Jacquier","year":"2022","journal-title":"South Afr Med J"},{"key":"R3-20260423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jecm.2014.01.011","article-title":"Infants with cancer: a unique population","volume":"6","author":"Chen","year":"2014","journal-title":"J Exp Clin Med"},{"key":"R5-20260423","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1542\/pir.2017-0057","article-title":"Pediatric solid tumors of infancy: an overview","volume":"39","author":"Allen-Rhoades","year":"2018","journal-title":"Pediatr Rev"},{"key":"R6-20260423","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pcl.2014.09.013","article-title":"Genetic and nongenetic risk factors for childhood cancer","volume":"62","author":"Spector","year":"2015","journal-title":"Pediatr Clin North Am"},{"key":"R7-20260423","first-page":"413","article-title":"Cancer registries can provide evidence-based data to improve quality of care and prevent cancer deaths","volume":"8","author":"Bouchardy","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"R8-20260423","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"key":"R9-20260423","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1200\/JCO.19.00261","article-title":"Outcome of Infants younger than 1 year with acute lymphoblastic leukemia treated with the Interfant-06 Protocol: results from an International Phase III Randomized Study","volume":"37","author":"Pieters","year":"2019","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"R10-20260423","first-page":"s124","article-title":"Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia","volume":"83","author":"Pui","year":"2004","journal-title":"Ann Hematol"},{"key":"R12-20260423","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pbc.21713","article-title":"Outcomes of the POG 9340\/9341\/9342 trials for children with high-risk neuroblastoma: a report from the Children\u2019s Oncology Group","volume":"51","author":"Zage","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R13-20260423","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1001527","article-title":"Outcome after reduced chemotherapy for intermediate-risk neuroblastoma","volume":"363","author":"Baker","year":"2010","journal-title":"N Engl J Med"},{"key":"R14-20260423","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1200\/JCO.2011.37.9990","article-title":"Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children\u2019s Oncology Group study P9641","volume":"30","author":"Strother","year":"2012","journal-title":"J Clin Oncol"},{"key":"R15-20260423","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1200\/JCO.2004.01.006","article-title":"Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study\u2014Pediatric Oncology Group 9048 and Children\u2019s Cancer Group 8891","volume":"22","author":"Rogers","year":"2004","journal-title":"J Clin Oncol"},{"key":"R16-20260423","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1200\/JCO.2015.63.4048","article-title":"Intensive multiagent therapy, including dose-compressed cycles of ifosfamide\/etoposide and vincristine\/doxorubicin\/cyclophosphamide, irinotecan, and radiation, in patients with high-risk rhabdomyosarcoma: a report from the Children\u2019s Oncology Group","volume":"34","author":"Weigel","year":"2016","journal-title":"J Clin Oncol"},{"key":"R17-20260423","doi-asserted-by":"crossref","first-page":"852185","DOI":"10.3389\/fped.2022.852185","article-title":"Multidisciplinary treatment strategies for Wilms\u2019 tumor: recent advances, technical innovations and future directions","volume":"10","author":"Theilen","year":"2022","journal-title":"Front Pediatr"},{"key":"R18-20260423","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpedsurg.2018.09.005","article-title":"Update on Wilms\u2019 tumor","volume":"54","author":"Aldrink","year":"2019","journal-title":"J Pediatr Surg"},{"key":"R19-20260423","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1200\/JCO.2010.34.4341","article-title":"Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children\u2019s Oncology Group study P9934","volume":"30","author":"Ashley","year":"2012","journal-title":"J Clin Oncol"},{"issue":"suppl 3","key":"R20-20260423","doi-asserted-by":"crossref","first-page":"iii318","DOI":"10.1093\/neuonc\/noaa222.187","article-title":"EPEN-54. ACNS0831, PHASE III randomized trial of post-radiation chemotherapy in patients with newly diagnosed ependymoma ages 1 to 21 years","volume":"22","author":"Smith","year":"2020","journal-title":"Neuro Oncol"},{"key":"R21-20260423","doi-asserted-by":"crossref","first-page":"437971","DOI":"10.1155\/2014\/437971","article-title":"Cancer incidence in Egypt: results of the national population-based cancer registry program","volume":"2014","author":"Ibrahim","year":"2014","journal-title":"J Cancer Epidemiol"},{"key":"R22-20260423","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1470-2045(08)70194-3","article-title":"Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving my child matters support: a descriptive study","volume":"9","author":"Ribeiro","year":"2008","journal-title":"Lancet Oncol"},{"key":"R24-20260423","first-page":"43","article-title":"Prevalence and outcome of malignant infant tumors seen at the Lagos University Teaching Hospital","volume":"3","author":"Akinsete","year":"2019","journal-title":"Niger Delta Med J"},{"key":"R25-20260423","first-page":"598","article-title":"Prevalence, clinical features and prognosis of malignant solid tumors in infants: a 14-year study","volume":"21","author":"Zhi","year":"2021","journal-title":"Bosn J Basic Med Sci"},{"key":"R26-20260423","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/APO.0000000000000060","article-title":"Predicted trends in the incidence of retinoblastoma in the Asia-Pacific region","volume":"3","author":"Usmanov","year":"2014","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R27-20260423","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1016\/S2214-109X(21)00598-2","article-title":"Retinoblastoma outcomes: a global perspective","volume":"10","author":"Paul","year":"2022","journal-title":"Lancet Glob Health"},{"key":"R28-20260423","doi-asserted-by":"crossref","first-page":"e28917","DOI":"10.1002\/pbc.28917","article-title":"Cancer incidence and survival trends among infants in the United States from 1975 to 2014","volume":"68","author":"Wang","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"R29-20260423","doi-asserted-by":"crossref","first-page":"e0130444","DOI":"10.1371\/journal.pone.0130444","article-title":"Infant cancer in Taiwan: incidence and trends (1995-2009)","volume":"10","author":"Hung","year":"2015","journal-title":"PLoS One"},{"key":"R30-20260423","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3109\/08880018.2013.852644","article-title":"A single center experience in 266 patients of infantile malignancies","volume":"31","author":"Das","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"R31-20260423","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/mpo.10153","article-title":"Cancer in neonates and infants","volume":"41","author":"Vasilatou-Kosmidis","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"R32-20260423","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1396::AID-CNCR25>3.0.CO;2-0","article-title":"Increased incidence of cancer in infants in the U.S.: 1980\u20131990","volume":"82","author":"Kenney","year":"1998","journal-title":"Cancer"},{"key":"R33-20260423","first-page":"418","article-title":"Past and future role of surgery in neuroblastoma","volume":"106","author":"Kaneko","year":"2005","journal-title":"Nippon Geka Gakkai Zasshi"},{"key":"R34-20260423","first-page":"574","article-title":"Malignant solid tumours in the first year of life","volume":"15","author":"Roguin","year":"1994","journal-title":"Harefuah"},{"key":"R35-20260423","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1016\/S2214-109X(21)00555-6","article-title":"Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors","volume":"10","author":"Wong","year":"2022","journal-title":"Lancet Glob Health"},{"key":"R36-20260423","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/pbc.22843","article-title":"Strategies to manage retinoblastoma in developing countries","volume":"56","author":"Chantada","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R38-20260423","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1182\/hematology.2022000359","article-title":"Updates in infant acute lymphoblastic leukemia and the potential for targeted therapy","volume":"2022","author":"Kotecha","year":"2022","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"R39-20260423","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/pd.2122","article-title":"Sacrococcygeal teratoma over two decades: birth prevalence, prenatal diagnosis and clinical outcomes","volume":"28","author":"Swamy","year":"2008","journal-title":"Prenat Diagn"},{"key":"R40-20260423","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/cam4.1122","article-title":"Neonates with cancer and causes of death: Lessons from 615 cases in the SEER databases","volume":"6","author":"Alfaar","year":"2017","journal-title":"Cancer Med"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:30:20Z","timestamp":1786037420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003190","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"2025-09-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}